Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

Eli Lilly expects to provide results from a study in people with obesity and osteoarthritis of the knee in 2025.

Multiple sclerosis (MS) in its end stages involves disabling and life threatening effects. Several home adaptations and palliative care are available and can improve survival, mobility ...

Pfizer said a late-stage study of its sasanlimab drug candidate met its key goal in certain patients with bladder cancer. Pfizer on Friday said the pivotal Phase 3 study evaluating sasanlimab in ...

LEXINGTON, Ky. (WDKY) — University of Kentucky researchers who are involved in a clinical trial on the use of medical cannabis for late-stage dementia patients say the results could be a game ...

Sanofi's Blood Cancer Drug's New Subcutaneous Formulation Hits Primary Goal In Late-Stage In Multiple Myeloma On Thursday, Sanofi SA (NASDAQ:SNY) released results from the IRAKLIA phase 3 study ...